Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 60429-975

8 FDA label images from Golden State Medical Supply, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 60429-975). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60429 975 30cb Ipratropium Bromide And Albuterol Sulfate

60429 975 30cb   Ipratropium Bromide And Albuterol Sulfate
Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution, 0.5 mg / 3 mg per 3 mL. The label indicates it is for oral inhalation only and comes in a package containing 30 sterile unit-dose vials, each vial containing 3 mL. The product is labeled by Golden State Medical Supply, Inc. and is identified with NDC 60429-975-30.*
FDA Label Image

Chemical Sturcture-albuterol Sulfate (Ipratropium 01)

Chemical Sturcture-albuterol Sulfate (Ipratropium 01)
Chemical structure of Ipratropium Bromide and Albuterol Sulfate active ingredients. The image shows the molecular formula with structural elements and sulfate groups.*
FDA Label Image

Chemical Structure-ipratropium Bromide (Ipratropium 02)

Chemical Structure-ipratropium Bromide (Ipratropium 02)
Chemical structure of Ipratropium Bromide, the active ingredient in the product Ipratropium Bromide and Albuterol Sulfate solution for respiratory inhalation by Golden State Medical Supply, Inc.*
FDA Label Image

Figure (Ipratropium 03)

Figure (Ipratropium 03)
A line graph showing lung function in liters over time in hours after dosing for Albuterol, Ipratropium, and their combination as Ipratropium Bromide and Albuterol Sulfate. The graph displays comparative effects on lung volume up to 8 hours post-dose.*
FDA Label Image

Figure 1 (Ipratropium 04)

Figure 1 (Ipratropium 04)
An instructional illustration showing the assembly or preparation of a respiratory inhalation device. The image depicts a person holding an inhaler and connecting it to a medication vial or chamber, likely representing part of the process to use Ipratropium Bromide and Albuterol Sulfate solution for inhalation.*
FDA Label Image

Figure 2 (Ipratropium 05)

Figure 2 (Ipratropium 05)
An instructional illustration showing how to connect or use a respiratory inhalation device, featuring a hand holding the device and an adapter piece being attached or positioned near the device nozzle.*
FDA Label Image

Figure 3 (Ipratropium 06)

Figure 3 (Ipratropium 06)
Two black and white instructional illustrations depict the use of a respiratory inhalation device for Ipratropium Bromide and Albuterol Sulfate solution. The first figure shows a person placing the mouthpiece in their mouth and inhaling. The second figure shows the same device with a face mask covering the nose and mouth inhaling the medication.*
FDA Label Image

Ritedone Logo (Ipratropium 07)

Ritedone Logo (Ipratropium 07)
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE inhalation solution, labeled with strengths of 2.5 mg and 0.5 mg per 3 mL. The packaging indicates respiratory route use and displays the Golden State Medical Supply, Inc. name and NDC 60429-975. The label is predominantly blue and white with medical-themed graphics.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.